In this randomized, double-blind, placebo-controlled, parallel-group, multi-center outcomes trial, patients with acutely decompensated heart failure will be randomized to receive placebo or Natrecor for a minimum of 24
The phase I monthly sustained release implant study showed that the treatment, Debio 9902, was well tolerated after repeated doses up to 15mg/per month and there were no
Diabetic peripheral neuropathic (DPN) pain is a common complication of diabetes that has significant impact on outcomes of concern to patients including sleep, activity and quality of life.
The study was conducted by ViRexx’s licensing partner, Unither Pharmaceuticals, a subsidiary of United Therapeutics Corporation. Patients with newly diagnosed advanced ovarian cancer were treated by surgery and
The study was a randomized, single-center, single-dose, six-period pilot study to evaluate four SmartRelief prototypes. The study compared sumatriptan pharmacokinetics and safety following administration of NP101 SmartRelief prototype
The lawsuit alleges that Dr Picker breached his written employment agreement with Callisto by accepting employment with Tapestry Pharmaceuticals in a manner not in accordance with his agreement.
<p>The so-called Study 102 showed that Viread is non-inferior to the company's once-daily antiviral drug Hepsera among patients with chronic hepatitis B virus (HBV) infection. The primary efficacy
Zetia is the first new cholesterol-lowering medication with a novel mechanism of action since statins were introduced 18 years ago in Japan, according to the companies. The drug
Humira is the first self-administered biologic for the treatment of Crohn’s disease and offers an effective and convenient treatment option that can help enable patients to maintain control
Nimotuzumab is a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). The single-arm trial, which will enroll approximately 40 patients, will be initiated shortly in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.